Melanoma News and Research

Latest Melanoma News and Research

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease.

6 May 2014

NCCN publishes new patient resource for stage 0 breast cancer

The National Comprehensive Cancer Network (NCCN), with the support of the NCCN Foundation®, announces the availability of the NCCN Guidelines for Patients: Breast Cancer Stages 0 - IV—the latest addition to the library of NCCN Guidelines for Patients available online free-of-charge at NCCN.org/patients.

6 May 2014

New research reveals that eczema may lower skin cancer risk

Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.

6 May 2014

Novogen partners with Genea Biocells to accelerate testing for neurodegenerative diseases

Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.

5 May 2014

ABCDE rule outlines warning signs of melanoma

It is estimated that one in five Americans will be diagnosed with skin cancer in the course of their lifetime, and one person dies from melanoma - the deadliest form of skin cancer - every hour.

2 May 2014

Sun tanning equals skin damage: New awareness campaign

It only takes a few bad sunburns or trips to the tanning bed to put someone at risk for melanoma. Skin cancer is the most common type of cancer in the United States and when left untreated, melanoma is the most dangerous and aggressive form. It accounts for more than 9,000 of the 12,000-plus skin cancer deaths each year. In observance of May's Melanoma and Skin Cancer Awareness Month Seattle Cancer Care Alliance (SCCA) is focusing on helping teens keep their skin safe this spring with a new infographic.

1 May 2014

Can-Fite BioPharma submits study protocol to FDA for CF102 Phase II trial for advanced liver cancer

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has submitted a study protocol to the U.S. Food and Drug Administration for its Phase II clinical trial of CF102 for the treatment of advanced liver cancer.

29 Apr 2014

Two internationally known scholars join Huntsman Cancer Institute

Two internationally known scholars, one in the field of cancer prevention and the other in the field of molecular biology, will join Huntsman Cancer Institute (HCI) at the University of Utah as early as Sept. 1.

29 Apr 2014

Single cell type actively suppressed in several experimental cancer vaccines

Most cancer vaccines have not lived up to their promise in clinical trials. The reason, many researchers suspect, is that the immune cells that would help the body destroy the tumor - even those reactions boosted by cancer vaccines - are actively suppressed.

29 Apr 2014

Skin Cancer Awareness Month and Melanoma Monday: Mount Sinai experts to share vital skin cancer tips

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. In recognition of May's Skin Cancer Awareness Month and Melanoma Monday on May 5th, Mount Sinai Health System experts are arming the public with vital tips on prevention and offering FREE skin cancer screenings.

26 Apr 2014

American Academy of Dermatology awarded 22 organizations with Shade Structure Grants

In an effort to provide children and adolescents more opportunities to play outside while being protected from the sun's dangerous rays, the American Academy of Dermatology (Academy) has awarded 22 organizations with Shade Structure Grants.

26 Apr 2014

Researchers develop new process to create inexpensive high quality lenses using hanging droplets

A droplet of clear liquid can bend light, acting as a lens. Now, by exploiting this well-known phenomenon, researchers have developed a new process to create inexpensive high quality lenses that will cost less than a penny apiece.

25 Apr 2014

OncoSec to present update of data from Phase 2 melanoma study at ASCO Annual Meeting

OncoSec Medical Inc., a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present an update of data from their Phase 2 melanoma study at the American Society of Clinical Oncology's 50th Annual Meeting, taking place May 30-June 3, 2014, at McCormick Place in Chicago, Illinois.

22 Apr 2014

Small gene embedded in large gene contributes to development of acute myeloid leukemia

A small gene that is embedded in a larger, well-known gene is the true leukemia-promoting force usually attributed to the larger gene, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

22 Apr 2014

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

21 Apr 2014

Researchers develop class of drugs to lessen impact of Alzheimer's, Parkinson's

A class of drugs developed to treat immune-related conditions and cancer - including one currently in clinical trials for glioblastoma and other tumors - eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.

17 Apr 2014

Top high school students build world's largest wiki on melanoma research

In a groundbreaking effort, 3,500 of the country's top high school students will build the world's largest wiki on melanoma research — and work toward finding that needle in a haystack to cure melanoma.

16 Apr 2014

Effects of PectaSol-C modified citrus pectin in prostate cancer patients to be studied in phase III trial

A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now recruiting participants to study the effects of dietary supplement PectaSol-C modified citrus pectin (MCP) in controlling prostate specific antigen (PSA) levels in prostate cancer patients.

15 Apr 2014

Study evaluates co-occurrence of cancers in patients with central nervous system disorders

The study evaluated the co-occurrence of cancers in patients with central nervous system disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, autism spectrum disorders, Down's syndrome, Huntington's disease, multiple sclerosis, Parkinson's disease and schizophrenia.

15 Apr 2014

Scientists identify enzyme that could be a useful target in treating asthma, cancer

In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.

11 Apr 2014

Melanoma News and Research

Latest Melanoma News and Research

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

NCCN publishes new patient resource for stage 0 breast cancer

New research reveals that eczema may lower skin cancer risk

Novogen partners with Genea Biocells to accelerate testing for neurodegenerative diseases

ABCDE rule outlines warning signs of melanoma

Sun tanning equals skin damage: New awareness campaign

Can-Fite BioPharma submits study protocol to FDA for CF102 Phase II trial for advanced liver cancer

Two internationally known scholars join Huntsman Cancer Institute

Single cell type actively suppressed in several experimental cancer vaccines

Skin Cancer Awareness Month and Melanoma Monday: Mount Sinai experts to share vital skin cancer tips

American Academy of Dermatology awarded 22 organizations with Shade Structure Grants

Researchers develop new process to create inexpensive high quality lenses using hanging droplets

OncoSec to present update of data from Phase 2 melanoma study at ASCO Annual Meeting

Small gene embedded in large gene contributes to development of acute myeloid leukemia

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Researchers develop class of drugs to lessen impact of Alzheimer's, Parkinson's

Top high school students build world's largest wiki on melanoma research

Effects of PectaSol-C modified citrus pectin in prostate cancer patients to be studied in phase III trial

Study evaluates co-occurrence of cancers in patients with central nervous system disorders

Scientists identify enzyme that could be a useful target in treating asthma, cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in